Bliretrigine
Product Specifications
UNSPSC Description
Bliretrigine is a sodium channel blocker. Bliretrigine has the effect of relieving pain[1][2][3].
Target Antigen
Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bliretrigine.html
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CCN1C2=CC(OC3=CC=C(C=C3)C)=CC=C2N=C1CN[C@@H](C)C(N)=O
Molecular Weight
352.43
References & Citations
[1]WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022.|[2]Yoshihiro OYAMADA, et al. External medicinal preparation containing N2-{[1-ethyl-6-(4-methylphenoxy)-1H-benzimidazol-2-yl]methyl}-L-alanineamide for treating and/or preventing peripheral neuropathic pain. Patent AU2019306705.|[3]Hironori Kinoshita, et al. Preparation of N2-[(benzimidazol-2-yl or imidazo[4,5-b]pyridin-2-yl)methyl]amino acid amide derivatives as inhibitors of sensory neuron specific sodium channel (SNS). Patent AU2009331179.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145558/Bliretrigine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145558/Bliretrigine-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1233229-75-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1008113-01 0.02 mg (E-Coli)
Recombinant Porphyromonas gingivalis 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB)
Ask
View Details